Infiltrating macrophages are key to the development of seizures following virus infection

Journal of Virology

Volumn 87, Issue 3, 2013, Pages 1849-1860

  Cusick, Matthew F ^a   Libbey, Jane E ^a   Patel, Dipan C ^b   Doty, Daniel J ^a   Fujinamia, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MINOCYCLINE; TUMOR NECROSIS FACTOR ALPHA; WOGONIN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; CELL ISOLATION; CELL POPULATION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; HIPPOCAMPAL CA2 REGION; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MICROGLIA; MONOCYTE; MOUSE; NATURAL KILLER CELL; NERVE EXCITABILITY; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SEIZURE; T LYMPHOCYTE;

ANIMALS; CARDIOVIRUS INFECTIONS; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROGLIA; SEIZURES; THEILOVIRUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873034256     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02747-12     Document Type: Article

References (53)

1. Libbey JE, Fujinami RS. 2011. Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus. Future Virol. 6:1339-1350.
2. Verboon-Maciolek MA, Krediet TG, Gerards LJ, de Vries LS, Groenendaal F, van Loon AM. 2008. Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr. Infect. Dis. J. 27:241-245.
3. Verboon-Maciolek MA, Krediet TG, Gerards LJ, Fleer A, van Loon TM. 2005. Clinical and epidemiologic characteristics of viral infections in a neonatal intensive care unit during a 12-year period. Pediatr. Infect. Dis. J. 24:901-904.
4. Wolthers KC, Benschop KS, Schinkel J, Molenkamp R, Bergevoet RM, Spijkerman IJ, Kraakman HC, Pajkrt D. 2008. Human parechoviruses as an important viral cause of sepsis-like illness and meningitis in young children. Clin. Infect. Dis. 47:358-363.
5. Libbey JE, Kirkman NJ, Smith MCP, Tanaka T, Wilcox KS, White HS, Fujinami RS. 2008. Seizures following picornavirus infection. Epilepsia 49:1066-1074.
6. Stewart K-AA, Wilcox KS, Fujinami RS, White HS. 2010. Theiler's virus infection chronically alters seizure susceptibility. Epilepsia 51:1418-1428.
7. Theiler M. 1937. Spontaneous encephalomyelitis of mice, a new virus disease. J. Exp. Med. 65:705-719.
8. Theiler M, Gard S. 1940. Encephalomyelitis of mice. I. Characteristics and pathogenesis of the virus. J. Exp. Med. 72:49-67.
9. Hou W, So EY, Kim BS. 2007. Role of dendritic cells in differential susceptibility to viral demyelinating disease. PLoS Pathog. 3:e124. doi:10 .1371/journal.ppat.0030124.
10. Olson JK, Girvin AM, Miller SD. 2001. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J. Virol. 75:9780-9789.
11. Palma JP, Kim BS. 2001. Induction of selected chemokines in glial cells infected with Theiler's virus. J. Neuroimmunol. 117:166-170.
12. Sethi P, Lipton HL. 1983. Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus. Br. J. Exp. Pathol. 64:57- 65.
13. Chang JR, Zaczynska E, Katsetos CD, Platsoucas CD, Oleszak EL. 2000. Differential expression of TGFβ, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice. Virology 278:346-360.
14. Inoue A, Koh C-S, Yahikozawa H, Yanagisawa N, Yagita H, Ishihara Y, Kim BS. 1996. The level of tumor necrosis factor-alpha producing cells in the spinal cord correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Int. Immunol. 8:1001- 1008.
15. Kirkman NJ, Libbey JE, Wilcox KS, White HS, Fujinami RS. 2010. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 51:454-464.
16. Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS. 2011. Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J. Virol. 85:6913- 6922.
17. Rubio N, Sanz-Rodriguez F, Lipton HL. 2006. Theiler's virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains. Cell. Immunol. 239:31- 40.
18. Theil DJ, Tsunoda I, Libbey JE, Derfuss TJ, Fujinami RS. 2000. Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J. Neuroimmunol. 104:22-30.
19. Libbey JE, Kirkman NJ, Wilcox KS, White HS, Fujinami RS. 2010. Role for complement in the development of seizures following acute viral infection. J. Virol. 84:6452- 6460.
20. Zurbriggen A, Fujinami RS. 1989. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J. Virol. 63:1505-1513.
21. + T cells during primary and secondary viral infections. J. Immunol. 174:5936-5940.
22. Tsunoda I, Wada Y, Libbey JE, Cannon TS, Whitby FG, Fujinami RS. 2001. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J. Virol. 75:7494-7505.
23. Benkovic SA, O'Callaghan JP, Miller DB. 2004. Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures. Brain Res. 1024:59-76.
24. Racine RJ. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:281-294.
25. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841- 845.
26. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 154:4309-4321.
27. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U. S. A. 88:7438-7442.
28. de Groot CJ, Huppes W, Sminia T, Kraal G, Dijkstra CD. 1992.Determination of the origin and nature of brain macrophages and microglial cells in mouse central nervous system, using non-radioactive in situ hybridization and immunoperoxidase techniques. Glia 6:301-309.
29. Hickey WF, Vass K, Lassmann H. 1992. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J. Neuropathol. Exp. Neurol. 51:246-256.
30. Krall WJ, Challita PM, Perlmutter LS, Skelton DC, Kohn DB. 1994. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood 83:2737-2748.
31. Matsumoto Y, Fujiwara M. 1987. Absence of donor-type major histocompatibility complex class I antigen-bearing microglia in the rat central nervous system of radiation bone marrow chimeras. J. Neuroimmunol. 17:71- 82.
32. Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS. 2011. Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection. J. Virol. 85:8149-8157.
33. Akassoglou K, Probert L, Kontogeorgos G, Kollias G. 1997. Astrocytespecific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:438-445.
34. Kalueff AV, Lehtimaki KA, Ylinen A, Honkaniemi J, Peltola J. 2004. Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neurosci. Lett. 365:106-110.
35. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. 1995. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. U. S. A. 92:11294-11298.
36. Fas SC, Baumann S, Zhu JY, Giaisi M, Treiber MK, Mahlknecht U, Krammer PH, Li-Weber M. 2006. Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis. Blood 108:3700- 3706.
37. Shao ZH, Li CQ, Vanden Hoek TL, Becker LB, Schumacker PT, Wu JA, Attele AS, Yuan CS. 1999. Extract from Scutellaria baicalensis Georgi attenuates oxidant stress in cardiomyocytes. J. Mol. Cell. Cardiol. 31: 1885-1895.
38. Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ. 2008. Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation. Proc. Natl. Acad. Sci. U. S. A. 105:17151-17156.
39. Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS. 2011. Once initiated, viral encephalitis-induced seizures are consistent no matter the treatment or lack of interleukin-6. J. Neurol. Virol. 17:496-499.
40. Vezzani A. 2005. Inflammation and epilepsy. Epilepsy Curr. 5:1- 6.
41. Fabene PF, Mora GN, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A, Zanetti L, Schio F, Osculati A, Marzola P, Nicolato E, Homeister JW, Xia L, Lowe JB, McEver RP, Osculati F, Sbarbati A, Butcher EC, Constantin G. 2008. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 14: 1377-1383.
42. Loup F, Wieser HG, Yonekawa Y, Aguzzi A, Fritschy JM. 2000. Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J. Neurosci. 20:5401-5419.
43. Zattoni M, Mura ML, Deprez F, Schwendener RA, Engelhardt B, Frei K, Fritschy JM. 2011. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J. Neurosci. 31:4037- 4050.
44. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83:64-70.
45. Nadeau S, Rivest S. 2000. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor B activity in the brain during endotoxemia. J. Neurosci. 20:3456-3468.
46. Funk JA, Gohlke J, Kraft AD, McPherson CA, Collins JB, Harry GJ. 2011. Voluntary exercise protects hippocampal neurons from trimethyltin injury: possible role of interleukin-6 to modulate tumor necrosis factor receptor-mediated neurotoxicity. Brain Behav. Immun. 25:1063-1077.
47. Bauer S, Kerr BJ, Patterson PH. 2007. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat. Rev. Neurosci. 8:221- 232.
48. Lacroix S, Chang L, Rose-John S, Tuszynski MH. 2002. Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J. Comp. Neurol. 454:213-228.
49. Abraham J, Fox PD, Condello C, Bartolini A, Koh S. 2012. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiol. Dis. 46:425- 430.
50. Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G, Batra A, Carlton E, Najm I, Granata T, Janigro D. 2009. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol. Dis. 33:171-181.
51. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, Bianchi ME, Vezzani A. 2010. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 16:413- 419.
52. Park HG, Yoon SY, Choi JY, Lee GS, Choi JH, Shin CY, Son KH, Lee YS, Kim WK, Ryu JH, Ko KH, Cheong JH. 2007. Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur. J. Pharmacol. 574: 112-119.
53. Polier G, Ding J, Konkimalla BV, Eick D, Ribeiro N, Kohler R, Giaisi M, Efferth T, Desaubry L, Krammer PH, Li-Weber M. 2011. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis. 2:e182.